Research Diagnosis Related Groups (DRG) level LOS quality outcomes for Baylor University Medical Center located at 3500 Gaston Ave, Dallas, TX, 75246 & includes data from NPIs 1184029811, 1447250253
Dexur analyzed Q4 2018 (October to December 2018) Medicare claims data to benchmark length of stay (LOS) outcomes for Baylor University Medical Center compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Oct 2018 to Dec 2018) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 2,920 | 2,749 | ||||||||||
| Surgical | 973 | 934 | ||||||||||
| Non Surgical | 1,947 | 1,815 | ||||||||||
| General Medicine | 499 | 437 | ||||||||||
| Cardiovascular | 389 | 368 | ||||||||||
| Orthopedics | 361 | 356 | ||||||||||
| General Surgery | 326 | 301 | ||||||||||
| Gastroenterology & Endocrinology | 316 | 308 | ||||||||||
| Pulmonology | 259 | 240 | ||||||||||
| Neurology | 258 | 240 | ||||||||||
| Urology | 175 | 173 | ||||||||||
| Oncology & Hematology | 126 | 123 | ||||||||||
| Spine | 69 | 69 | ||||||||||
| Colorectal | 64 | 61 | ||||||||||
| Obesity, Bariatric, Stomach & Duodenal | 35 | 35 | ||||||||||
| Obstetrics & Gynecology | 21 | 21 | ||||||||||
| Psychiatry & Mental Disorders | 16 | 11 |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Oct 2018 to Dec 2018) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 870: SEPTICEMIA OR SEVERE SEPSIS WITH MV >96 HOURS | ||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
| DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Disorders Of Liver Except Malignancy, Cirrhosis And Alcoholic Hepatitis | ||||||||||||
| DRG 441: DISORDERS OF LIVER EXCEPT MALIGNANCY, CIRRHOSIS OR ALCOHOLIC HEPATITIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 442: DISORDERS OF LIVER EXCEPT MALIGNANCY, CIRRHOSIS OR ALCOHOLIC HEPATITIS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Cellulitis | ||||||||||||
| DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Poisoning And Toxic Effects Of Drugs | ||||||||||||
| DRG 917: POISONING AND TOXIC EFFECTS OF DRUGS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cirrhosis And Alcoholic Hepatitis | ||||||||||||
| Signs And Symptoms |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Oct 2018 to Dec 2018) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heart Failure And Shock | ||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Coronary Bypass | ||||||||||||
| DRG 236: CORONARY BYPASS WITHOUT CARDIAC CATHETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 235: CORONARY BYPASS WITHOUT CARDIAC CATHETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
| DRG 308: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Hypertension | ||||||||||||
| DRG 305: HYPERTENSION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Vascular Procedures | ||||||||||||
| DRG 252: OTHER VASCULAR PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Circulatory System Diagnoses | ||||||||||||
| DRG 314: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Syncope And Collapse | ||||||||||||
| DRG 312: SYNCOPE AND COLLAPSE | ||||||||||||
| Peripheral Vascular Disorders | ||||||||||||
| Cardiac Valve And Other Major Cardiothoracic Procedures | ||||||||||||
| Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||
| Acute Myocardial Infarction |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Oct 2018 to Dec 2018) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Major Joint And Limb Reattachment Procedures Of Upper Extremity | ||||||||||||
| DRG 483: MAJOR JOINT/LIMB REATTACHMENT PROCEDURE OF UPPER EXTREMITIES | ||||||||||||
| Revision Of Hip Or Knee Replacement | ||||||||||||
| DRG 467: REVISION OF HIP OR KNEE REPLACEMENT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Hip And Femur Procedures Except Major Joint | ||||||||||||
| DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Lower Extremity And Humerus Procedures Except Hip,Foot,Femur | ||||||||||||
| DRG 493: LOWER EXTREMITY AND HUMERUS PROCEDURES EXCEPT HIP, FOOT AND FEMUR WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Other Musculoskeletal System And Connective Tissue O.R. Procedures | ||||||||||||
| DRG 516: OTHER MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE O.R. PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Fractures Of Hip And Pelvis | ||||||||||||
| DRG 536: FRACTURES OF HIP AND PELVIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Medical Back Problems | ||||||||||||
| DRG 552: MEDICAL BACK PROBLEMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Oct 2018 to Dec 2018) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
| DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 854: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Extensive O.R. Procedure Unrelated To Principal Diagnosis | ||||||||||||
| DRG 981: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Major Chest Procedures | ||||||||||||
| DRG 165: MAJOR CHEST PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Ecmo Or Tracheostomy With Mv >96 Hours Or Pdx Except Face, Mouth And Neck | ||||||||||||
| DRG 003: ECMO OR TRACHEOSTOMY WITH MV >96 HOURS OR PDX EXCEPT FACE, MOUTH AND NECK WITH MAJOR O.R. PROCEDURE | ||||||||||||
| Craniotomy And Endovascular Intracranial Procedures | ||||||||||||
| DRG 025: CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Postoperative Or Post-Traumatic Infections With O.R. Procedure | ||||||||||||
| Other Respiratory System O.R. Procedures | ||||||||||||
| Hernia Procedures | ||||||||||||
| Non-Extensive Procedure Unrelated To Principal Diagnosis |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Oct 2018 to Dec 2018) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| G.I.Hemorrhage | ||||||||||||
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 391: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| G.I. Obstruction | ||||||||||||
| DRG 389: G.I. OBSTRUCTION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Other Digestive System Diagnoses | ||||||||||||
| DRG 394: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Diabetes | ||||||||||||
| DRG 638: DIABETES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Major Gastrointestinal Disorders And Peritoneal Infections | ||||||||||||
| Disorders Of Pancreas Except Malignancy | ||||||||||||
| Disorders Of Biliary Tract | ||||||||||||
| Cholecystectomy | ||||||||||||
| Endocrine Disorders |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Oct 2018 to Dec 2018) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Simple Pneumonia And Pleurisy | ||||||||||||
| DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Pulmonary Edema And Respiratory Failure | ||||||||||||
| DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | ||||||||||||
| Respiratory System Diagnosis With Ventilator Support | ||||||||||||
| DRG 208: RESPIRATORY SYSTEM DIAGNOSIS W VENTILATOR SUPPORT <=96 HOURS | ||||||||||||
| Chronic Obstructive Pulmonary Disease | ||||||||||||
| DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Pulmonary Embolism | ||||||||||||
| Other Respiratory System Diagnoses | ||||||||||||
| Respiratory Infections And Inflammations |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Oct 2018 to Dec 2018) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
| DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | ||||||||||||
| DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 066: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Nonspecific Cerebrovascular Disorders | ||||||||||||
| DRG 070: NONSPECIFIC CEREBROVASCULAR DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Traumatic Stupor And Coma, Coma < 1 Hour | ||||||||||||
| DRG 086: TRAUMATIC STUPOR AND COMA, COMA <1 HOUR WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Traumatic Stupor And Coma, Coma > 1 Hour | ||||||||||||
| Seizures | ||||||||||||
| DRG 101: SEIZURES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Ischemic Stroke With Use Of Thrombolytic Agent | ||||||||||||
| Other Disorders Of Nervous System |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Oct 2018 to Dec 2018) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kidney And Urinary Tract Infections | ||||||||||||
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Renal Failure | ||||||||||||
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Kidney And Urinary Tract Diagnoses | ||||||||||||
| DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 699: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Kidney And Ureter Procedures |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Oct 2018 to Dec 2018) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Red Blood Cell Disorders | ||||||||||||
| DRG 812: RED BLOOD CELL DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 811: RED BLOOD CELL DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Lymphoma And Non-Acute Leukemia | ||||||||||||
| DRG 840: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Chemotherapy Without Acute Leukemia As Secondary Diagnosis | ||||||||||||
| Digestive Malignancy |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Oct 2018 to Dec 2018) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Spinal Fusion Except Cervical | ||||||||||||
| DRG 460: SPINAL FUSION EXCEPT CERVICAL WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cervical Spinal Fusion | ||||||||||||
| Combined Anterior/Posterior Spinal Fusion |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Oct 2018 to Dec 2018) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Small And Large Bowel Procedures | ||||||||||||
| DRG 330: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 329: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 331: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Oct 2018 to Dec 2018) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stomach, Esophageal And Duodenal Procedures |